Showing results (81-90 of 115) with videos related to
Sort By:
Pageof 12
Oncotarget|March 31, 2018
Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patientsMasako Ishikawa, Kentaro Nakayama, Kohei Nakamura, et al.Cancer|December 6, 2011
Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinomaMohammed Tanjimur Rahman, Kentaro Nakayama, Munmun Rahman, et al.Archives of Gynecology and Obstetrics|May 22, 2020
High PD-1 expression level is associated with an unfavorable prognosis in patients with cervical adenocarcinomaMasako Ishikawa, Kentaro Nakayama, Kohei Nakamura, et al.Oncology Letters|June 11, 2017
Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancerKentaro Nakayama, Munmun Rahman, Mohammed Tanjimur Rahman, et al.Anticancer Research|September 12, 2013
ESR1 gene amplification in endometrial carcinomas: a clinicopathological analysisMohammed Tanjimur Rahman, Kentaro Nakayama, Munmun Rahman, et al.International Journal of Molecular Sciences|July 4, 2013
KRAS and MAPK1 gene amplification in type II ovarian carcinomasMohammed Tanjimur Rahman, Kentaro Nakayama, Munmun Rahman, et al.Current Oncology (Toronto, Ont.)|June 23, 2022
Promising Therapeutic Impact of a Selective Estrogen Receptor Downregulator, Fulvestrant, as Demonstrated In Vitro upon Low-Grade Serous Ovarian Carcinoma Cell LinesKamrunnahar Shanta, Kentaro Nakayama, Mohammad Mahmud Hossain, et al.Anticancer Research|December 26, 2012
PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypesMunmun Rahman, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 2016
High pretreatment plasma D-dimer levels are related to shorter overall survival in endometrial carcinomaKohei Nakamura, Kentaro Nakayama, Masako Ishikawa, et al.Anticancer Research|June 9, 2016
High Pre-treatment Plasma D-Dimer Level as a Potential Prognostic Biomarker for Cervical CarcinomaKohei Nakamura, Kentaro Nakayama, Masako Ishikawa, et al.Pageof 12